VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q86423243 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241121000105.0
008 241121nneanz||abbn n and d
035 ‎‡a (WKP)Q86423243‏
024 ‎‡a 0000-0002-5545-9674‏ ‎‡2 orcid‏
024 ‎‡a 55886509500‏ ‎‡2 scopus‏
035 ‎‡a (OCoLC)Q86423243‏
100 0 ‎‡a Bing Li‏ ‎‡c researcher (ORCID 0000-0002-5545-9674)‏ ‎‡9 en‏
670 ‎‡a Author's C-Phycocyanin exerts anti-cancer effects via the MAPK signaling pathway in MDA-MB-231 cells.‏
670 ‎‡a Author's Carboxymethyl chitosan nanoparticles coupled with CD59-specific ligand peptide for targeted delivery of C-phycocyanin to HeLa cells.‏
670 ‎‡a Author's CD59 underlines the antiatherosclerotic effects of C-phycocyanin on mice.‏
670 ‎‡a Author's Molecular mechanism of inhibitory effects of C-phycocyanin combined with all-trans-retinoic acid on the growth of HeLa cells in vitro.‏
670 ‎‡a Author's Molecular mechanism of inhibitory effects of CD59 gene on atherosclerosis in ApoE‏
670 ‎‡a Author's Molecular mechanism of inhibitory effects of CD59 gene on atherosclerosis in ApoE (-/-) mice.‏
670 ‎‡a Author's Phycocyanin: A Potential Drug for Cancer Treatment‏
670 ‎‡a Author's Study of the synergistic effects of all-transretinoic acid and C-phycocyanin on the growth and apoptosis of A549 cells.‏
670 ‎‡a Author's The synergistic antitumor effects of all-trans retinoic acid and C-phycocyanin on the lung cancer A549 cells in vitro and in vivo.‏
670 ‎‡a Author's The Targeted Antitumor Effects of C- PC/CMC-CD59sp Nanoparticles on HeLa Cells in Vitro and in Vivo.‏
909 ‎‡a (orcid) 0000000255459674‏ ‎‡9 1‏
909 ‎‡a (scopus) 55886509500‏ ‎‡9 1‏
919 ‎‡a molecularmechanismofinhibitoryeffectsof100phycocyanincombinedwithalltransretinoicacidonthegrowthofhelacellsinvitro‏ ‎‡A Molecular mechanism of inhibitory effects of C-phycocyanin combined with all-trans-retinoic acid on the growth of HeLa cells in vitro.‏ ‎‡9 1‏
919 ‎‡a targetedantitumoreffectsof100pccmccd59spnanoparticlesonhelacellsinvitroandinvivo‏ ‎‡A The Targeted Antitumor Effects of C- PC/CMC-CD59sp Nanoparticles on HeLa Cells in Vitro and in Vivo.‏ ‎‡9 1‏
919 ‎‡a studyofthesynergisticeffectsofalltransretinoicacidand100phycocyaninonthegrowthandapoptosisofa549cells‏ ‎‡A Study of the synergistic effects of all-transretinoic acid and C-phycocyanin on the growth and apoptosis of A549 cells.‏ ‎‡9 1‏
919 ‎‡a phycocyaninapotentialdrugforcancertreatment‏ ‎‡A Phycocyanin: A Potential Drug for Cancer Treatment‏ ‎‡9 1‏
919 ‎‡a molecularmechanismofinhibitoryeffectsofcd59geneonatherosclerosisinapoemice‏ ‎‡A Molecular mechanism of inhibitory effects of CD59 gene on atherosclerosis in ApoE (-/-) mice.‏ ‎‡9 1‏
919 ‎‡a molecularmechanismofinhibitoryeffectsofcd59geneonatherosclerosisinapoe‏ ‎‡A Molecular mechanism of inhibitory effects of CD59 gene on atherosclerosis in ApoE‏ ‎‡9 1‏
919 ‎‡a carboxymethylchitosannanoparticlescoupledwithcd59specificligandpeptidefortargeteddeliveryof100phycocyanintohelacells‏ ‎‡A Carboxymethyl chitosan nanoparticles coupled with CD59-specific ligand peptide for targeted delivery of C-phycocyanin to HeLa cells.‏ ‎‡9 1‏
919 ‎‡a 100phycocyaninexertsanticancereffectsviathemapksignalingpathwayinmdamb231cells‏ ‎‡A C-Phycocyanin exerts anti-cancer effects via the MAPK signaling pathway in MDA-MB-231 cells.‏ ‎‡9 1‏
919 ‎‡a cd59underlinestheantiatheroscleroticeffectsof100phycocyaninonmice‏ ‎‡A CD59 underlines the antiatherosclerotic effects of C-phycocyanin on mice.‏ ‎‡9 1‏
919 ‎‡a synergisticantitumoreffectsofalltransretinoicacidand100phycocyaninonthelungcancera549cellsinvitroandinvivo‏ ‎‡A The synergistic antitumor effects of all-trans retinoic acid and C-phycocyanin on the lung cancer A549 cells in vitro and in vivo.‏ ‎‡9 1‏
996 ‎‡2 PLWABN|9812619634705606
996 ‎‡2 DNB|173604773
996 ‎‡2 DNB|1185227296
996 ‎‡2 DNB|104133737X
996 ‎‡2 ISNI|0000000042124926
996 ‎‡2 ISNI|0000000064074747
996 ‎‡2 DNB|1339688093
996 ‎‡2 LC|no2012133290
996 ‎‡2 ISNI|0000000063672702
996 ‎‡2 SUDOC|261394509
996 ‎‡2 BNF|16505347
996 ‎‡2 DNB|1256014885
996 ‎‡2 CYT|AC000641925
996 ‎‡2 NTA|364183853
996 ‎‡2 J9U|987007311912405171
996 ‎‡2 LC|n 88103166
996 ‎‡2 RERO|A017579134
996 ‎‡2 DNB|1038155274
996 ‎‡2 DNB|1069571814
996 ‎‡2 PTBNP|1261049
996 ‎‡2 CAOONL|ncf10339649
996 ‎‡2 NSK|000698403
996 ‎‡2 BIBSYS|90802613
996 ‎‡2 ISNI|0000000073783879
996 ‎‡2 ISNI|000000006350360X
996 ‎‡2 ISNI|0000000456472613
996 ‎‡2 LIH|LNB:C_z__y___;=CQ
996 ‎‡2 DNB|1100066098
996 ‎‡2 DNB|1126608599
996 ‎‡2 NII|DA00920610
996 ‎‡2 ISNI|0000000109770296
996 ‎‡2 DNB|173885489
996 ‎‡2 NKC|jx20071204013
996 ‎‡2 NII|DA07167729
996 ‎‡2 ISNI|0000000078992880
996 ‎‡2 SUDOC|187424276
996 ‎‡2 J9U|987007575410905171
996 ‎‡2 SZ|1161880321
996 ‎‡2 ISNI|0000000495511785
996 ‎‡2 DNB|120700300X
996 ‎‡2 CYT|AC000632219
996 ‎‡2 DNB|1021375810
996 ‎‡2 NTA|202145549
996 ‎‡2 NKC|xx0164959
996 ‎‡2 NTA|258637315
996 ‎‡2 DNB|1136617930
996 ‎‡2 DNB|1251789293
996 ‎‡2 DNB|111772378X
996 ‎‡2 ISNI|0000000505840284
996 ‎‡2 ISNI|0000000063779227
996 ‎‡2 ISNI|0000000112285865
996 ‎‡2 DNB|1046378309
996 ‎‡2 BNF|15792550
996 ‎‡2 DNB|1200559347
996 ‎‡2 NTA|07485822X
996 ‎‡2 LC|n 2017070310
996 ‎‡2 DNB|121998972X
996 ‎‡2 CYT|AC000640277
996 ‎‡2 CYT|AC000599785
996 ‎‡2 DNB|1160000700
996 ‎‡2 LC|nr 95029972
996 ‎‡2 SUDOC|236319647
996 ‎‡2 LC|n 88047071
996 ‎‡2 LC|nr2001049125
996 ‎‡2 ISNI|000000007736089X
996 ‎‡2 DNB|1272550982
996 ‎‡2 DNB|1317258290
996 ‎‡2 NSK|000695691
996 ‎‡2 NSK|000741698
996 ‎‡2 PLWABN|9813264266005606
996 ‎‡2 NII|DA12479028
996 ‎‡2 SUDOC|14040824X
996 ‎‡2 CYT|AC000633200
996 ‎‡2 ISNI|0000000110642777
996 ‎‡2 CYT|AC000000245
996 ‎‡2 NTA|391540793
996 ‎‡2 CYT|AC000582194
996 ‎‡2 DNB|1145966608
996 ‎‡2 DNB|1194506348
996 ‎‡2 DNB|1076410081
996 ‎‡2 ISNI|0000000444633168
996 ‎‡2 LC|nr 92021806
996 ‎‡2 LC|nr 92004189
996 ‎‡2 DNB|1249851076
996 ‎‡2 LC|n 2015001617
996 ‎‡2 DNB|1325131156
996 ‎‡2 DBC|87097969246621
996 ‎‡2 DNB|104167919X
996 ‎‡2 ISNI|0000000054620038
996 ‎‡2 LC|no2001100414
996 ‎‡2 ISNI|0000000108903755
996 ‎‡2 ISNI|0000000394259920
996 ‎‡2 ISNI|0000000064348744
996 ‎‡2 ISNI|0000000084220764
996 ‎‡2 LC|no2020060588
996 ‎‡2 LC|n 81106498
996 ‎‡2 LNB|LNC10-000202150
996 ‎‡2 LC|no2020060429
996 ‎‡2 LC|n 2014066148
996 ‎‡2 ISNI|0000000445532465
996 ‎‡2 LC|no2019191620
996 ‎‡2 DNB|129225436X
996 ‎‡2 PLWABN|9811780944305606
996 ‎‡2 NTA|401998754
996 ‎‡2 NUKAT|nx2024013126
996 ‎‡2 LC|no2015016840
996 ‎‡2 DNB|139435638
996 ‎‡2 LC|no2012125731
996 ‎‡2 CYT|AC000585992
996 ‎‡2 ISNI|0000000084419474
996 ‎‡2 BNF|16262500
996 ‎‡2 CYT|AC000636291
996 ‎‡2 DNB|1305487044
996 ‎‡2 KRNLK|KAC200608381
996 ‎‡2 LNB|LNC10-000192022
996 ‎‡2 CYT|AC000653080
996 ‎‡2 NSK|000727720
996 ‎‡2 ISNI|0000000500476153
996 ‎‡2 ISNI|0000000064333526
996 ‎‡2 LC|n 2019050705
996 ‎‡2 CAOONL|ncf11038965
996 ‎‡2 ISNI|0000000063610827
996 ‎‡2 DNB|1149186917
996 ‎‡2 PLWABN|9812079819605606
996 ‎‡2 ISNI|0000000386892953
996 ‎‡2 DNB|1154897869
996 ‎‡2 DNB|118764306
996 ‎‡2 CYT|AC000008403
996 ‎‡2 DNB|173581676
996 ‎‡2 CAOONL|ncf10324973
996 ‎‡2 DNB|1060035553
996 ‎‡2 CAOONL|ncf11056185
996 ‎‡2 KRNLK|KAC200802337
996 ‎‡2 BIBSYS|1656998781087
996 ‎‡2 CYT|AC000216570
996 ‎‡2 DNB|1077636334
996 ‎‡2 ISNI|0000000064242990
996 ‎‡2 DNB|1316841294
996 ‎‡2 ISNI|0000000064228398
996 ‎‡2 BIBSYS|90674893
996 ‎‡2 LC|n 82065583
996 ‎‡2 LC|n 85824448
996 ‎‡2 DNB|1254693319
996 ‎‡2 ISNI|0000000371021987
996 ‎‡2 CYT|AC000653607
996 ‎‡2 BNF|15109507
996 ‎‡2 CAOONL|ncf11448311
996 ‎‡2 PLWABN|9812746097805606
996 ‎‡2 CYT|AC000468621
996 ‎‡2 ISNI|0000000063765271
996 ‎‡2 LC|nr 94022391
996 ‎‡2 ISNI|0000000075524440
996 ‎‡2 LC|n 2015048230
996 ‎‡2 RERO|A023349728
996 ‎‡2 LC|n 85074093
996 ‎‡2 ISNI|0000000065203723
996 ‎‡2 ISNI|0000000063748455
996 ‎‡2 CYT|AC000424547
996 ‎‡2 SUDOC|223713716
996 ‎‡2 DNB|141971177
996 ‎‡2 DNB|1044496886
996 ‎‡2 DNB|1013557085
996 ‎‡2 ISNI|0000000063924957
996 ‎‡2 DNB|1157918220
996 ‎‡2 J9U|987007334976305171
996 ‎‡2 ISNI|0000000063194229
996 ‎‡2 BNF|16722828
996 ‎‡2 DNB|1221969587
996 ‎‡2 LC|n 97024042
996 ‎‡2 ISNI|0000000044330248
996 ‎‡2 DNB|143217380
996 ‎‡2 CYT|AC000654062
996 ‎‡2 CAOONL|ncf10341298
996 ‎‡2 BIBSYS|90360358
996 ‎‡2 LC|n 79034019
996 ‎‡2 ISNI|0000000081940432
996 ‎‡2 BIBSYS|9072741
996 ‎‡2 NII|DA13477957
996 ‎‡2 RERO|A003519057
996 ‎‡2 DNB|1216118981
996 ‎‡2 LC|no2015072809
996 ‎‡2 DNB|1188493442
996 ‎‡2 LC|nr 92027600
996 ‎‡2 LC|n 86019616
996 ‎‡2 CYT|AC000643526
996 ‎‡2 LC|n 95060735
996 ‎‡2 SUDOC|166948349
996 ‎‡2 DNB|1113596643
996 ‎‡2 J9U|987007421938505171
996 ‎‡2 ISNI|0000000080628658
996 ‎‡2 SUDOC|19317281X
996 ‎‡2 RERO|A024945624
996 ‎‡2 LC|no2012074428
996 ‎‡2 CAOONL|ncf10331858
996 ‎‡2 SUDOC|146459490
996 ‎‡2 DNB|1254291903
996 ‎‡2 NTA|217385214
996 ‎‡2 ISNI|0000000070985045
996 ‎‡2 LC|n 2022011812
996 ‎‡2 ISNI|0000000354592227
996 ‎‡2 LC|no2020060098
996 ‎‡2 NTA|145841413
996 ‎‡2 DNB|1026218292
996 ‎‡2 LC|no2020102973
996 ‎‡2 CYT|AC000007827
996 ‎‡2 J9U|987007381280005171
996 ‎‡2 LC|n 2017040331
996 ‎‡2 CAOONL|ncf10430218
996 ‎‡2 ISNI|0000000063293710
996 ‎‡2 ISNI|0000000368000544
996 ‎‡2 DNB|1306292182
996 ‎‡2 ISNI|0000000084830650
996 ‎‡2 PLWABN|9810681707905606
996 ‎‡2 DNB|116155551X
996 ‎‡2 LC|n 84048865
996 ‎‡2 RERO|A003519023
996 ‎‡2 RERO|A003519022
996 ‎‡2 NKC|jcu2011664650
996 ‎‡2 RERO|A000104732
996 ‎‡2 DNB|1334799741
996 ‎‡2 NYNYRILM|390815
996 ‎‡2 RERO|A000104731
996 ‎‡2 ISNI|0000000046820195
996 ‎‡2 LC|n 83133025
996 ‎‡2 DNB|1137497815
996 ‎‡2 NKC|utb2017941889
996 ‎‡2 CYT|AC000273602
996 ‎‡2 DNB|1194436560
996 ‎‡2 NUKAT|n 2015131857
996 ‎‡2 ISNI|000000043383436X
996 ‎‡2 LC|nr 91004945
996 ‎‡2 LC|n 2005007367
996 ‎‡2 DNB|1336726504
996 ‎‡2 LC|n 2004054140
996 ‎‡2 DNB|1280658606
996 ‎‡2 ISNI|0000000064091184
996 ‎‡2 LC|n 00047749
996 ‎‡2 ISNI|000000038281304X
996 ‎‡2 PLWABN|9810591857605606
996 ‎‡2 PLWABN|9810585861305606
996 ‎‡2 LC|nb2018024383
996 ‎‡2 LC|n 2012047918
996 ‎‡2 ISNI|0000000063285331
996 ‎‡2 DNB|1067640266
996 ‎‡2 LC|n 88643296
996 ‎‡2 ISNI|0000000109067365
996 ‎‡2 LC|no2019097191
996 ‎‡2 ISNI|0000000041760146
996 ‎‡2 ISNI|0000000052338258
996 ‎‡2 ISNI|000000006368480X
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏